Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NeoFox: Foxy-5 in Colon Cancer
NCT03883802Phase 2Unknown
- Sponsor
- WntResearch AB
- Start
- Apr 2019
- Primary completion
- Dec 2024
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Foxy-5 in colon cancer, sponsored by WntResearch AB. Status: unknown.
02
Drugs
Foxy-5
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT03883802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03883802.